Posted by Michael Wonder on 01 Dec 2021
VBI Vaccines announces FDA approval of PreHevbrio for the prevention of Hepatitis B in adults
1 December 2021 - PreHevbrio is the only approved 3 antigen hepatitis B vaccine for adults in the U.S.
VBI Vaccines today announced that the U.S. FDA has approved PreHevbrio [hepatitis B vaccine (recombinant)] for the prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older.
